Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK14 | Q16539 | 10/20 | 0.60 |
| ▸ | MAPK13 | O15264 | 2/20 | 0.60 |
| ▸ | MAPK12 | P53778 | 2/20 | 0.60 |
| ▸ | MAPK11 | Q15759 | 2/20 | 0.60 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.59 |
| ▸ | HPGD | P15428 | 1/20 | 0.59 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.59 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 4/20 | 0.38 |
| ▸ | MAPT | P10636 | 4/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | GAA | P10253 | 2/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7374155 | 0.90 | MAPK14 (0.60) | MAPK14MAPK13MAPK12MAPK11TDP1 | |
| SCHEMBL11502671 | 0.83 | MAPK14 (0.76) | MAPK14MAPK13MAPK12MAPK11TDP1 | |
| SCHEMBL9297762 | 0.83 | MAPK14 (0.52) | MAPK14MAPK13MAPK12MAPK11TDP1 | |
| SCHEMBL9436245 | 0.82 | MAPK14 (0.84) | MAPK14MAPK13MAPK12MAPK11TDP1 | |
| SCHEMBL7377237 | 0.80 | PDE10A (0.51) | MAPK14MAPK13MAPK12MAPK11TDP1 | |
| SCHEMBL9298106 | 0.78 | TGFBR1 (0.43) | MAPK14MAPK13MAPK12MAPK11TDP1 | |
| SCHEMBL9748155 | 0.78 | MAPK14 (0.76) | MAPK14MAPK13MAPK12MAPK11TDP1 | |
| SCHEMBL7378916 | 0.75 | MAPK14 (1.00) | MAPK14MAPK13MAPK12MAPK11TDP1 | |
| SCHEMBL146947 | 0.75 | MAPK14 (1.00) | MAPK14MAPK13MAPK12MAPK11TDP1 | |
| SCHEMBL9340169 | 0.75 | MAPK14 (0.71) | MAPK14MAPK13MAPK12MAPK11TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1990015534-A1 | MONOKINE ACTIVITY INTERFERENCE | SMITHKLINE BEECHAM CORPORATION (US) | 1990-12-27 | — | — | WO | claimed |
| EP-0321490-B1 | INHIBITION OF INTERLEUKIN-1 PRODUCTION BY MONOCYTES AND/OR MACROPHAGES | SMITHKLINE BEECHAM CORP (US) | 1994-06-22 | — | — | EP | disclosed |
| US-5317019-A | Antiinflammatory agents | SMITHKLINE BEECHAM CORP. (US) | 1994-05-31 | — | — | US | disclosed |
| EP-0411754-A2 | Medicament for the inhibition of interleukin-1 or tumor necrosis factor production by monocytes and/or macrophages | SMITHKLINE BEECHAM CORPORATION (US) | 1991-02-06 | — | — | EP | disclosed |
| WO-1991000092-A1 | INHIBITION OF INTERLEUKIN-1 AND TUMOR NECROSIS FACTOR PRODUCTION BY MONOCYTES AND/OR MACROPHAGES | SMITHKLINE BEECHAM CORPORATION (US) | 1991-01-10 | — | — | WO | disclosed |
| WO-1990015534-A1 | MONOKINE ACTIVITY INTERFERENCE | SMITHKLINE BEECHAM CORPORATION (US) | 1990-12-27 | — | — | WO | disclosed |
| EP-0403251-A2 | Monokine activity interference | SMITHKLINE BEECHAM CORPORATION (US) | 1990-12-19 | — | — | EP | disclosed |
| EP-0321490-A4 | INHIBITION OF INTERLEUKIN-1 PRODUCTION BY MONOCYTES AND/OR MACROPHAGES. | SMITHKLINE BECKMAN CORP (US) | 1990-05-14 | — | — | EP | disclosed |
| EP-0321490-A1 | INHIBITION OF INTERLEUKIN-1 PRODUCTION BY MONOCYTES AND/OR MACROPHAGES. | SMITHKLINE BECKMAN CORP (US) | 1989-06-28 | — | — | EP | disclosed |
| WO-1988001169-A1 | INHIBITION OF INTERLEUKIN-1 PRODUCTION BY MONOCYTES AND/OR MACROPHAGES | SMITHKLINE BECKMAN CORPORATION (US) | 1988-02-25 | — | — | WO | disclosed |
| US-4175127-A | ANTIARTHRITIC AGENTS | SMITHKLINE CORPORATION (US) | 1979-11-20 | — | — | US | disclosed |